Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Congress Holding Marathon Oil Corporation (MRO) Oil’s Future in its Hands

Page 1 of 2

So far, 2013 has been a shaky year for exploration and production companies. Marathon Oil Corporation (NYSE:MRO) represents that trend well. The Jan. 16 attack on the natural gas plant in Algeria, run jointly by  Statoil ASA (ADR) (NYSE:STO), BP plc (ADR) (NYSE:BP), and Algerian Sonatrach caused a negative ripple effect on most E&P companies with North African operations, Marathon Oil included.

A lackluster Q4 2012 didn’t help matters either, despite posting slightly higher revenues than the previous quarter, EPS came in at $0.45 per share, down 29% from the previous quarter and 42% year on year. Between reporting Q4 2012 results on Feb. 22 and March 1, the company’s share price sunk about 5%.

Personally, I feel this represents an opportunity to purchase a great energy company at a discount. When evaluating potential long-term investments, The Motley Fool favors the ‘SWOT’ method. A balanced look at Strengths, Weaknesses, Opportunities, and Threats facing Marathon Oil Corporation (NYSE:MRO) should help us decide if its recent price weakness is an opportunity, or a sign to back off.

Strengths:

Consistent growth of shareholder equity

In June 2011, Marathon Oil Corporation (NYSE:MRO) spun off its refining business into Marathon Petroleum Corp (NYSE:MPC). At that time, shareholders received one share of the new downstream company for every two shares of common stock previously held in Marathon Oil. All downstream operations at Marathon Oil ceased after the split. Although it was a difficult transition, when viewed as a whole, the two companies managed to retain their book value immediately following the split. Since then, long-term investors have enjoyed steady growth from both companies, an especially impressive feat for a highly cyclical commodity-based businesses.

Marathon Oil Shareholder Equity data by YCharts

Although Marathon Petroleum is also a fine company, it may be trading at too much of a premium at the moment. The Ohio-based refiner hit a 52-week high on March 1, 2013. Several U.S.-based downstream companies are getting a great deal of attention lately. Domestic oil and gas production has experienced explosive growth in the past few years. Refineries located in the Mid-West, like Marathon Petroleum, are taking advantage of cheap domestic oil and gas, and then selling it based on globally determined prices. If the Brent-WTI spread narrows, a pullback in refinery profitability is likely.

Consistently performing base assets

Viewed annually, Marathon Oil has not posted a loss since 1995. One of the reasons for its rock-steady growth are its stable group of base assets. Oil sands mining in Canada, liquids rich plays in the Eagle Ford and Bakken shales, and highly profitable conventional oil wells in Libya are just a few of Marathons diverse base assets. Their consistent production allows the company to safely invest in numerous growth and exploration projects using cash, instead of taking on heavy levels of debt.

Map Source: Marathon Oil Annual Report 2012

Weakness:
African instability

The Waha Oil Company is an enormous consortium led by Libya’s National Oil Company (NOC). Foreign oil companies operating in partnership with the NOC include Marathon Oil, ConocoPhillips (NYSE:COP) , and Hess Corp. (NYSE:HES) . During Libya’s civil war in 2011, the Waha Oil Consortium ceased operations for most of the year. Further turmoil within Libya could result in losses for Marathon Oil and the rest of the Waha consortium.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!